Superworth

Scynexis market cap SCYX

Share price times shares outstanding: what the whole company sells for, since 2014.

Today, Nov 2, 2026
$37.9M
Highest close in our data
$197.6M
May 2021

Scynexis is worth $37.9M at the close on Nov 2, 2026, at $3.81 a share.

That is up 52% over the last year and down 71% over five years.

Its highest close in our data was $197.6M in May 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$37.9M$26.8M$58.8M+54%
2025$24.7M$24.6M$53.5M−35%
2024$37.9M$37.9M$104.7M−54%
2023$83M$37.6M$135.7M+63%
2022$50.9M$50.9M$151.6M−65%
2021$146.1M$81.7M$197.6M+75%
2020$83.7M$46.3M$97.4M+64%
2019$50.9M$29.5M$91.8M+101%
2018$25.4M$18.4M$92.3M−62%
2017$66.3M$41.3M$86.8M−13%
2016$76.5M$28.1M$116.2M−11%
2015$86.4M$67.2M$130.3M−3%
2014$89M$54.1M$95.3Mn/a

Against its peers

Companies in Drug Manufacturers - General nearest Scynexis' size, closest first, today.

CompanyMarket cap
SCYXScynexis$37.9M
ATNMActinium Pharmaceuticals$45M
SPROSpero Therapeutics$60.6M
LFVNLifevantage$73.5M
NATRNatures Sunshine Products$211.5M
Peer median$67M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Scynexis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.